loadpatents
Patent applications and USPTO patent grants for Rappaport; Jay.The latest application filed is for "monomac-1 cells expressing cd16 and cd163".
Patent | Date |
---|---|
MonoMac-1 Cells Expressing CD16 and CD163 App 20200018745 - Rappaport; Jay ;   et al. | 2020-01-16 |
Detection of HIV-1-associated neurocognitive disorders Grant 10,161,925 - Merali , et al. Dec | 2018-12-25 |
Detection of HIV-1-Associated Neurocognitive Disorders App 20170176408 - Merali; Salim ;   et al. | 2017-06-22 |
Blood monocyte CD163 expression as a biomarker in HIV-1 infection and neuroaids Grant 8,273,538 - Rappaport , et al. September 25, 2 | 2012-09-25 |
Blood Monocyte Cd163 Expression As A Biomarker In Hiv-1 Infection And Neuroaids App 20100291595 - Rappaport; Jay ;   et al. | 2010-11-18 |
Treatment Of Hiv-1 By Modulation Of Vpr Activation Of The M-csf Promoter App 20090117155 - Rappaport; Jay ;   et al. | 2009-05-07 |
Carboxymethylated retroviral regulatory proteins and interferon-.alpha. Grant 7,022,326 - Zagury , et al. April 4, 2 | 2006-04-04 |
Mutated HIV Tat App 20040005330 - Rappaport, Jay ;   et al. | 2004-01-08 |
NCAGE Code | 48FY3 | RAPPAPORT JAY |
CAGE Code | 48FY3 | RAPPAPORT, JAY |
DUNS | 612198650 | RAPPAPORT, JAY |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.